Italy Crispr And Cas Genes Market Size & Outlook
Italy crispr and cas genes market, 2018-2030 (US$M)
Related Markets
Italy crispr and cas genes market highlights
- The Italy crispr and cas genes market generated a revenue of USD 44.1 million in 2023 and is expected to reach USD 108.0 million by 2030.
- The Italy market is expected to grow at a CAGR of 13.7% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
Crispr and cas genes market data book summary
| Market revenue in 2023 | USD 44.1 million |
| Market revenue in 2030 | USD 108.0 million |
| Growth rate | 13.7% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
Other key industry trends
- In terms of revenue, Italy accounted for 1.4% of the global crispr and cas genes market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany crispr and cas genes market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 350.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR And Cas Genes Market Scope
CRISPR And Cas Genes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy crispr and cas genes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crispr and cas genes market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 78.46% in 2023. Horizon Databook has segmented the Italy crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
Research collaborations and agreement models among international CRISPR providers and research institutes, as well as other biotech companies of Italy, is expected to drive the country’s CRISPR market.
This agreement is expected to support an integrated discovery service platform of Axim. As a result of the agreement, application of CRISPR technology is expected to expand development of highly customized cell-based assays.
In June 2017, Italy’s San Raffaele University and Research Hospital entered into a three-year research collaboration with Italia Therapeutics, Inc., a U.S.-based biotechnology company, to harness the latter’s CRISPR/Cas9 genome editing technology.
Reasons to subscribe to Italy crispr and cas genes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy crispr and cas genes market databook
-
Our clientele includes a mix of crispr and cas genes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy crispr and cas genes market , including forecasts for subscribers. This country databook contains high-level insights into Italy crispr and cas genes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy crispr and cas genes market size, by product & service, 2018-2030 (US$M)
Italy CRISPR And Cas Genes Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
